Turco Luigi Carlo, Vizzielli Giuseppe, Vargiu Virginia, Gueli Alletti Salvatore, De Ninno Maria, Ferrandina Gabriella, Pedone Anchora Luigi, Scambia Giovanni, Cosentino Francesco
Department of Women's and Children's Health, Fondazione Policlinico Universitario A. Gemelli IRCCS, Rome, Italy.
Department of Gynecologic Oncology, Gemelli Molise, Campobasso, Italy.
Front Oncol. 2021 Nov 15;11:737938. doi: 10.3389/fonc.2021.737938. eCollection 2021.
A current challenge for endometriosis surgery is to correctly identify the localizations of disease, especially when small or hidden (occult endometriosis), and to exactly define their real extension. The use of near-infrared radiation imaging (NIR) after injection of indocyanine green (ICG) represents one of the most encouraging method. The aim of this study is to assess the diagnostic value of NIR-ICG imaging in the surgical treatment of endometriosis compared with the standard of treatment.
The Gre-Endo trial is a prospective, single-arm study (NCT03332004). After exploring the operatory field using the white light (WL) mode, patients were injected with ICG and then observed in NIR mode. All suspected areas were classified and chronicled according to lesions visualized only in WL, NIR-ICG, or in the combination of both. Lesion not visualized in WL was considered as suspect occult lesion (s-OcL). In addition, a random control biopsy from an apparent negative peritoneum visualized in WL and NIR-ICG imaging was taken for all patients (control cases). All lesions removed were considered "suspect endometriosis" until pathology.
Fifty-one patients were enrolled between January 2016 and October 2019. A total of 240 suspected lesions have been identified with both methods (WL + NIR-ICG). Two hundred and seven (86.2%) lesions out of the overall 240 were visualized with WL imaging, and 200 were confirmed to be pathologic (true positive for WL). The remaining 33/240 (13.75%) (false negative for WL) lesions were identified only with NIR-ICG imaging and collected as s-OcL. All 33 s-OcLs removed were confirmed to be pathologic (c-OcL = 100%). NIR-ICG vision showed PPV of 98.5%, NPV of 87.1%, Se of 87%, and Sp of 98.5%, confirming that this kind of imaging is an excellent diagnostic and screening test ( = 0.001 and = 0.835, according to McNemar's and Cohen's kappa tests, respectively).
The use of NIR-ICG vision alone and combined with WL showed good results in intraoperative detection rate and fluorescence-guided surgery of endometriosis. Furthermore, NIR-ICG allowed surgeons to remove occult lesions that otherwise would remain, leading to possible greater postoperative pain and a higher risk of persistence and relapse.
子宫内膜异位症手术当前面临的一项挑战是正确识别疾病的位置,尤其是在病灶较小或隐匿(隐匿性子宫内膜异位症)时,并准确界定其实际范围。注射吲哚菁绿(ICG)后使用近红外辐射成像(NIR)是最具前景的方法之一。本研究旨在评估NIR-ICG成像在子宫内膜异位症手术治疗中相对于治疗标准的诊断价值。
Gre-Endo试验是一项前瞻性单臂研究(NCT03332004)。在使用白光(WL)模式探查手术区域后,给患者注射ICG,然后以NIR模式进行观察。所有可疑区域根据仅在WL、NIR-ICG或两者组合中可见的病变进行分类和记录。在WL中未见到的病变被视为可疑隐匿性病变(s-OcL)。此外所有患者(对照病例)均从WL和NIR-ICG成像中显示为明显阴性的腹膜处随机进行对照活检。所有切除的病变在病理检查之前均被视为“可疑子宫内膜异位症”。
2016年1月至2019年10月共纳入51例患者。两种方法(WL + NIR-ICG)共识别出240个可疑病变。240个病变中共有207个(86.2%)在WL成像中可见其中200个经病理证实(WL的真阳性)。其余33/240(13.75%)(WL的假阴性)病变仅通过NIR-ICG成像识别并作为s-OcL收集。所有切除的33个s-OcL均经病理证实(c-OcL = 100%)。NIR-ICG视觉显示阳性预测值为98.5%阴性预测值为87.1%灵敏度为87%特异度为98.5%证实这种成像方式是一种出色的诊断和筛查测试(根据McNemar检验和Cohen's kappa检验分别为 = 0.001和 = 0.835)。
单独使用NIR-ICG视觉并与WL相结合在子宫内膜异位症的术中检测率和荧光引导手术中显示出良好效果。此外NIR-ICG使外科医生能够切除否则可能会残留的隐匿性病变这可能导致术后疼痛加剧以及持续和复发风险升高。